×
About 3,513 results

ALLMedicine™ Anticoagulation Center

Research & Reviews  1,661 results

Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenati...
https://doi.org/10.1371/journal.pone.0249854
PloS One; Lv X, Deng M et. al.

Apr 8th, 2021 - To compare the safety and efficacy of low-dose anticoagulation (LA) with that of standardized dose anticoagulation (SA) for patients supported with extracorporeal membrane oxygenation (ECMO). PubMed, MEDLINE, the Cochrane Library, and Web of Scien...

Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: R...
https://doi.org/10.1161/CIRCULATIONAHA.120.050117
Circulation Kar S, Doshi SK et. al.

Apr 6th, 2021 - Background: Left atrial appendage (LAA) occlusion provides an alternative to oral anticoagulation (OAC) for thromboembolic risk reduction in patients with non-valvular atrial fibrillation (NVAF). Since regulatory approval in 2015, the WATCHMAN dev...

Real-World Experience With Antiplatelet Agents After Percutaneous Coronary Intervention...
https://doi.org/10.1097/FJC.0000000000000973
Journal of Cardiovascular Pharmacology; Tanner R, Cronin M et. al.

Apr 5th, 2021 - Patients undergoing percutaneous coronary intervention (PCI) with a clinical indication for oral anticoagulation (OAC) in addition to antiplatelet therapy (APT) necessitate rigorous evaluation of bleeding and ischemic risk to guide therapy. The op...

Regional Citrate Anticoagulation for CKRT With Calcium-Containing Solutions: A Cohort S...
https://doi.org/10.1053/j.ajkd.2021.01.017
American Journal of Kidney Diseases : the Official Journa... Rhee H, Berenger B et. al.

Apr 2nd, 2021 - Regional citrate anticoagulation (RCA) is the preferred anticoagulation method for continuous kidney replacement therapy (CKRT) recommended by the KDIGO guidelines. Limited availability of calcium-free solutions often imposes challenges to the imp...

see more →

Guidelines  7 results

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.119.040267
Circulation Schnabel RB,et al

Nov 25th, 2019 - Cardiac thromboembolism attributed to atrial fibrillation (AF) is responsible for up to one-third of ischemic strokes. Stroke may be the first manifestation of previously undetected AF. Given the efficacy of oral anticoagulants in preventing AF-re...

Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report
https://journal.chestnet.org/article/S0012-3692(18)32244-X/abstract
Lip, G.,et al.

Nov 27th, 2018 - The risk of stroke is heterogeneous across different groups of patients with atrial fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide recommendations for antithrombotic treatment based on net clinical be.

American Society of Hematology 2018 guidelines for management of venous thromboembolism: opt...
http://www.bloodadvances.org/content/2/22/3257
Witt, D.

Nov 26th, 2018 - Background: Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat venous thromboembolism (VTE). Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support.

Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline...
http://www.learnicu.org/SiteCollectionDocuments/VTE-Prophylaxis-Neuro-Guideline.pdf
Paul Nyquist

Dec 7th, 2015 - The risk of death from venous thromboembolism (VTE) is high in intensive care unit patients with neurological diagnoses. This is due to an increased risk of venous stasis secondary to paralysis as well as an increased prevalence of underlying path.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  1,749 results

Low vs standardized dose anticoagulation regimens for extracorporeal membrane oxygenati...
https://doi.org/10.1371/journal.pone.0249854
PloS One; Lv X, Deng M et. al.

Apr 8th, 2021 - To compare the safety and efficacy of low-dose anticoagulation (LA) with that of standardized dose anticoagulation (SA) for patients supported with extracorporeal membrane oxygenation (ECMO). PubMed, MEDLINE, the Cochrane Library, and Web of Scien...

Parity Whether Anticoagulation Is Halted or Not for Unplanned Cath
https://www.medscape.com/viewarticle/949064

Apr 8th, 2021 - Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major reg...

Primary Outcome Evaluation of a Next Generation Left Atrial Appendage Closure Device: R...
https://doi.org/10.1161/CIRCULATIONAHA.120.050117
Circulation Kar S, Doshi SK et. al.

Apr 6th, 2021 - Background: Left atrial appendage (LAA) occlusion provides an alternative to oral anticoagulation (OAC) for thromboembolic risk reduction in patients with non-valvular atrial fibrillation (NVAF). Since regulatory approval in 2015, the WATCHMAN dev...

Real-World Experience With Antiplatelet Agents After Percutaneous Coronary Intervention...
https://doi.org/10.1097/FJC.0000000000000973
Journal of Cardiovascular Pharmacology; Tanner R, Cronin M et. al.

Apr 5th, 2021 - Patients undergoing percutaneous coronary intervention (PCI) with a clinical indication for oral anticoagulation (OAC) in addition to antiplatelet therapy (APT) necessitate rigorous evaluation of bleeding and ischemic risk to guide therapy. The op...

see more →

News  95 results

Parity Whether Anticoagulation Is Halted or Not for Unplanned Cath
https://www.medscape.com/viewarticle/949064

Apr 8th, 2021 - Maintaining oral anticoagulation (OAC) throughout an unplanned cardiac catheterization confers no extra risk and might hold some advantages over periprocedural OAC interruption in patients on long-term anticoagulation therapy, suggests a major reg...

Left Atrial Appendage Occlusion, DOAC Comparable for AFib
https://www.medscape.com/viewarticle/944133

Jan 13th, 2021 - Left atrial appendage occlusion (LAAO) for high-risk atrial fibrillation seems to prevent stroke as well as direct oral anticoagulation (DOAC) with a lower risk of major bleeding, according to results of a European study. And although some experts...

'Low-Risk' Valvular AF in Some May be Risky Enough for Oral Anticoagulation
https://www.staging.medscape.com/viewarticle/937294

Sep 10th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...

'Low-Risk' Valvular AF in Some May be Risky Enough for Oral Anticoagulation
https://www.medscape.com/viewarticle/937294

Sep 10th, 2020 - Some patients with "valvular" atrial fibrillation (AF) and stroke-risk scores low enough for oral anticoagulation (OAC) not to be indicated may actually face enough thromboembolic risk to justify the lifelong therapy, a new report suggests. The co...

Mini-Dose Edoxaban May Safely Cut AF Stroke Risk in the Frail, Very Elderly
https://www.staging.medscape.com/viewarticle/936684

Aug 31st, 2020 - An ultra-low dose of direct oral anticoagulant (DOAC) may safely cut the risk for stroke in very elderly patients with atrial fibrillation (AF) whose bleeding risk is considered too high for standard dosages, suggests a randomized trial conducted ...

see more →